StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
GHBullishAnalyst Target Updateanalyst
High materiality7/10

BTIG raises Guardant Health price target to $210 and reiterates Top Pick

Oct 27, 2026, 8:32 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

The target increase and Top Pick designation are a meaningful positive analyst catalyst, although the view is limited to one firm's opinion.

AI summary

What happened, with direct paths to the underlying reporting

BTIG raised its GH price target to $210; the posted price was $173.25, implying about 21% upside to the target. The firm also described GH as a Top Pick.

  • BTIG price target: $210 versus posted price of $173.25.
  • The target implies roughly 21% upside; analyst targets are opinions, not forecasts.

Key facts

  1. 01

    Target: $210

  2. 02

    Posted price: $173.25

  3. 03

    Analyst firm: BTIG

  4. 04

    Analyst: Mark Massaro

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event